Purdue Has Always Accounted for Small Portion of Industry Spending on Lobbying

$2.7 billion

Pharmaceutical manufacturing industry spending on lobbying, 1998-2019[1]

$12 million

Purdue Pharma spending on lobbying, 2001-2019[2]

Purdue also spent well over $1 billion on anti-abuse and diversion efforts.

Top 20 Lobbying Spenders & Campaign Contributors From 1999-2018 Does Not Include Purdue Pharma[3]

Purdue spent 0.4% of the total amount the top 20 spenders put towards lobbying.

RankOrganization$ MillionsPercent
1Pharmaceutical Research and Manufacturers of America422.316.2
2Pfizer219.28.4
3Amgen192.77.4
4Eli Lilly and Company166.26.4
5Biotechnology Innovation Organization153.45.9
6Merck143.05.5
7Roche Holdings135.95.2
8Novartis130.25.0
9Johnson & Johnson129.95.0
10Sanofi116.74.5
11Bayer111.04.3
12GlaxoSmithKline110.84.3
13Bristol-Myers Squibb101.63.9
14Abbott Laboratories96.63.7
15Advanced Medical Technology Association79.43.0
16Seniors Coalition65.32.5
17Medtronic63.82.4
18Baxter International58.42.2
19AstraZeneca54.62.1
20Teva Pharmaceutical Industries53.32.0
Total2604.3

Lobbying Expenditures for Ensuring Patient Access and Effective Drug Enforcement Act

$105,000,000

Pharmaceutical Industry Total[4]

$400,000

Purdue Total[2]

Purdue Spending on Private Organizations Was Modest

Purdue Spending on Private Organizations: 1997-2012

Purdue Spending on Private Organizations: 1997-2012